The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Wright Medical Group NV

Nasdaq: WMGI
Last

(U.S.) $19.31

Today's change-0.01 -0.05%
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

Wright Medical Group NV

Nasdaq: WMGI
Last

(U.S.) $19.31

Today's change-0.01 -0.05%
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.

Wright Medical Group NV down slightly

Wright Medical Group NV closed down just (U.S.)$0.01 Friday to (U.S.)$19.31. Over the last five days, shares have gained 1.10%, but are down 20.14% for the last year to date. Shares have underperformed the S&P 500 by 25.76% during the last year.

Key company metrics

  • Open(U.S.) $19.34
  • Previous close(U.S.) $19.32
  • High(U.S.) $19.41
  • Low(U.S.) $19.14
  • Bid / Ask(U.S.) $0.00 / (U.S.) $21.00
  • YTD % change-20.14%
  • Volume1,176,498
  • Average volume (10-day)2,563,372
  • Average volume (1-month)1,331,156
  • Average volume (3-month)1,076,188
  • 52-week range(U.S.) $15.02 to (U.S.) $27.06
  • Beta1.16
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.70
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-53.60%

Wright Medical Group NV has a net profit margin of -53.60%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.40%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 27, 201603/27/2016Dec 27, 201512/27/2015Sep 27, 201509/27/2015Jun 28, 201506/28/2015
Revenue1811697583
Total other revenue--------
Total revenue1811697583
Gross profit1291055965
Total cost of revenue52641619
Total operating expense2103408390
Selling / general / administrative1392555559
Research & development132356
Depreciation / amortization7544
Interest expense (income), net operating--------
Unusual expense (income)---732
Other operating expenses, total--------
Operating income-29-171-9-7
Interest income (expense), net non-operating-12-37-1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax-40-219-10-9
Income after tax-39-213-11-9
Income tax, total-1-611
Net income-48-273-11-9
Total adjustments to net income--------
Net income before extra. items-39-213-11-9
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-39-213-11-9
Inc. avail. to common incl. extra. items-48-273-11-9
Diluted net income-48-273-11-9
Dilution adjustment--------
Diluted weighted average shares1031124949
Diluted EPS excluding extraordinary itemsvalue per share-0.38-1.90-0.22-0.19
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.38-1.94-0.18-0.16
R